Evidence map›Paper›PMID 35480253›Full record

ArticleRSC advances2021

Validation of an insertion-engineered isoprene synthase as a strategy to functionalize terpene synthases.

C Raul Gonzalez-Esquer, Bryan Ferlez, Sarathi M Weraduwage, Henning Kirst, Alexandra T Lantz, Aiko Turmo, Thomas D Sharkey, Cheryl A Kerfeld

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

C Raul Gonzalez-EsquerMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Bryan FerlezMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Sarathi M WeraduwageMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Henning KirstMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Alexandra T LantzMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Aiko TurmoMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Thomas D SharkeyMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Cheryl A KerfeldMSU-DOE Plant Research Laboratory, Michigan State University East Lansing MI 48824 USA ckerfeld@lbl.gov.
Michigan State University · USLawrence Berkeley National Laboratory · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Terpene synthases are biotechnologically-relevant enzymes with a variety of applications. However, they are typically poor catalysts and have been difficult to engineer. Structurally, most terpene synthases share two conserved domains (α- and β-domains). Some also contain a third domain containing a second active site (γ-domain). Based on the three-domain architecture, we hypothesized that αβ terpene synthases could be engineered by insertion of a heterologous domain at the site of the γ-domain (an approach we term "Insertion-engineering terpene synthase"; Ie-TS). We demonstrate that by mimicking the domain architecture of αβγ terpene synthases, we can redesign isoprene synthase (ISPS), an αβ terpene synthase, while preserving enzymatic activity. Insertion of GFP or a SpyCatcher domain within ISPS introduced new functionality while maintaining or increasing catalytic turnover. This insertion-engineering approach establishes that the γ-domain position is accessible for incorporation of additional sequence features and enables the rational engineering of terpene synthases for biotechnology.

Identifiers

PMID35480253
PMCPMC9041124
OpenAlexW3198702271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.